SLU-PP-332 is a synthetic compound currently under investigation in preclinical research. Studies in laboratory models indicate that it interacts with Estrogen-Related Receptors (ERRs), a family of nuclear receptors involved in the regulation of cellular energy balance, mitochondrial activity, and lipid metabolism.
By modulating ERR activity, SLU-PP-332 has been used in experimental settings to explore pathways related to metabolic regulation and energy utilisation.
Preclinical Research on SLU-PP-332
In controlled laboratory studies, primarily involving mice and other preclinical models, SLU-PP-332 has been investigated for a range of potential biological effects:
- Energy Expenditure & Body Composition: Some studies report increased energy utilisation and changes in fat metabolism, associated with reductions in body weight and adiposity in obese mouse models.
- Exercise-Related Pathways: Research indicates activation of metabolic pathways typically triggered by physical activity, leading to more efficient use of cellular energy.
- Endurance Capacity: In murine models, stimulation of mitochondrial biogenesis and enhanced fat utilisation have been observed, correlating with improved exercise capacity.
- Muscle Physiology: Findings suggest an increase in oxidative muscle fibre proportions, linked with more efficient muscular performance in animal models.
- Metabolic Function: Certain studies report improvements in insulin sensitivity and glucose tolerance, highlighting possible relevance for metabolic research.
- Tolerability in Preclinical Settings: Early animal studies have not identified severe or notable adverse effects under controlled conditions.
Note: All findings summarised above are from preclinical research only. SLU-PP-332 is supplied strictly for laboratory and research use. It is not for human or veterinary consumption.
Buy it now or find our more about us.
Featured Products
